Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells

Brain Research

Volumn 1334, Issue , 2010, Pages 25-30

  Arun, Peethambaran ^a   Moffett, John R ^a   Namboodiri, Aryan M A ^a  

^a Department of Anatomy   (United States)

Author keywords

Amyotrophic lateral sclerosis; Glutamate; Magnetic resonance spectroscopy; NAA; NAAG

Indexed keywords

GLUTAMIC ACID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; RILUZOLE;

AMINO ACID SYNTHESIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HUMAN CELL; NERVE CELL EXCITABILITY; NEUROBLASTOMA CELL; NEUROTRANSMISSION; PRIORITY JOURNAL;

ASPARTIC ACID; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEUROBLASTOMA; RILUZOLE; TIME FACTORS;

EID: 77952101691     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.001     Document Type: Article

References (38)

1. Ajit G.T., Corse A.M., Coccia C.F., Bilak M.M., Rothstein J.D., and Slusher B.S. NAALADase inhibition protects motor neurons against chronic glutamate toxicity. Eur. J. Pharmacol. 471 (2003) 177-184
2. Arun P., Madhavarao C.N., Hershfield J.R., Moffett J.R., and Namboodiri M.A. SH-SY5Y neuroblastoma cells: a model system for studying biosynthesis of NAAG. NeuroReport 15 (2004) 1167-1170
3. Arun P., Madhavarao C.N., Moffett J.R., and Namboodiri A.M. Regulation of N-acetylaspartate and N-acetylaspartylglutamate biosynthesis by protein kinase activators. J. Neurochem. 98 (2006) 2034-2042
4. Arun P., Madhavarao C.N., Moffett J.R., and Namboodiri A.M. Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. J. Neurochem. 106 (2008) 1669-1680
5. Arun P., Moffett J.R., and Namboodiri A.M. Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Neurochem. Int. 55 (2009) 219-225
6. Corona J.C., Romo L.B., and Tapia R. Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert. Opin. Ther. Targets 11 (2007) 1415-1428
7. Danielsen E.R., and Ross B. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases (1999), Marcel Dekker, New York
8. Foran E., and Trotti D. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 11 (2009) 1587-1602
9. Gehl L.M., Saab O.H., Bzdega T., Wroblewska B., and Neale J.H. Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J. Neurochem. 90 (2004) 989-997
10. Harris K., Lin A., Bhattacharya P., Tran T., Wong W., and Ross B.D. Regulation of NAA-synthesis in the human brain in vivo: Canavan's disease, Alzheimer's disease and schizophrenia. In: Moffett J.R., Tieman S.B., Weinberger D.R., Coyle J.T., and Namboodiri M.A. (Eds). N-Acetylaspartate: a Unique Neuronal Molecule in the Central Nervous System Vol. 576 (2006), Springer Science, New York, NY 263-273
11. Kalra S., and Arnold D.L. ALS surrogate markers, MRS. Amyotroph. Lateral. Scler. Other Motor Neuron Disord. 5 Suppl 1 (2004) 111-114
12. Kalra S., and Arnold D.L. Magnetic resonance spectroscopy for monitoring neuronal integrity in amyotrophic lateral sclerosis. In: Moffett J.R., Tieman S.B., Weinberger D.R., Coyle J.T., and Namboodiri M.A. (Eds). N-Acetylaspartate: a Unique Neuronal Molecule in the Central Nervous System Vol. 576 (2006), Springer Science, New York, NY 275-282
13. Kalra S., Arnold D.L., and Cashman N.R. Biological markers in the diagnosis and treatment of ALS. J. Neurol. Sci. 165 Suppl 1 (1999) S27-S32
14. Kalra S., Cashman N.R., Genge A., and Arnold D.L. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. NeuroReport 9 (1998) 1757-1761
15. Kalra S., Tai P., Genge A., and Arnold D.L. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J. Neurol. (2006)
16. Matalon R., Michals K., and Kaul R. Canavan disease: from spongy degeneration to molecular analysis. J. Pediatr. 127 (1995) 511-517
17. Mathew S.J., Price R.B., Mao X., Smith E.L., Coplan J.D., Charney D.S., and Shungu D.C. Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder. Biol. Psychiatry 63 (2008) 891-898
18. McMillan C.R., Sharma R., Ottenhof T., and Niles L.P. Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells. Neurosci. Lett. 419 (2007) 202-206
19. Miller R.G., Jackson C.E., Kasarskis E.J., England J.D., Forshew D., Johnston W., Kalra S., Katz J.S., Mitsumoto H., Rosenfeld J., Shoesmith C., Strong M.J., and Woolley S.C. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73 (2009) 1218-1226
20. Miller R.G., Mitchell J.D., Lyon M., and Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane. Database. Syst. Rev. (2007) CD001447
21. Moffett J.R., Ross B., Arun P., Madhavarao C.N., and Namboodiri A.M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81 (2007) 89-131
22. Neale J.H., Olszewski R.T., Gehl L.M., Wroblewska B., and Bzdega T. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol. Sci. 26 (2005) 477-484
23. Nogradi A., Szabo A., Pinter S., and Vrbova G. Delayed riluzole treatment is able to rescue injured rat spinal motoneurons. Neurosci. 144 (2007) 431-438
24. Oyarce A.M., and Fleming P.J. Multiple forms of human dopamine beta-hydroxylase in SH-SY5Y neuroblastoma cells. Arch. Biochem. Biophys. 290 (1991) 503-510
25. Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann. Neurol. 28 (1990) 3-8
26. Plaitakis A., and Constantakakis E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis. Brain Res. Bull. 30 (1993) 381-386
27. Presgraves S.P., Ahmed T., Borwege S., and Joyce J.N. Terminally differentiated SH-SY5Y cells provide a model system for studying neuroprotective effects of dopamine agonists. Neurotox. Res. 5 (2004) 579-598
28. Rooney W.D., Miller R.G., Gelinas D., Schuff N., Maudsley A.A., and Weiner M.W. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 50 (1998) 1800-1805
29. Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65 Suppl 1 (2009) S3-S9
30. Rothstein J.D., Tsai G., Kuncl R.W., Clawson L., Cornblath D.R., Drachman D.B., Pestronk A., Stauch B.L., and Coyle J.T. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28 (1990) 18-25 [see comments]
31. Rule R.R., Suhy J., Schuff N., Gelinas D.F., Miller R.G., and Weiner M.W. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph. Lateral. Scler. Other Motor Neuron Disord. 5 (2004) 141-149
32. Schwartz G., and Fehlings M.G. Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J. Neurosurg. 94 (2001) 245-256
33. Tranberg M., Stridh M.H., Guy Y., Jilderos B., Wigstrom H., Weber S.G., and Sandberg M. NMDA-receptor mediated efflux of N-acetylaspartate: physiological and/or pathological importance?. Neurochem. Int. 45 (2004) 1195-1204
34. Tsai G.C., Stauch-Slusher B., Sim L., Hedreen J.C., Rothstein J.D., Kuncl R., and Coyle J.T. Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS. Brain Res. 556 (1991) 151-156
35. Van Damme P., Dewil M., Robberecht W., and Van Den Bosch L. Excitotoxicity and amyotrophic lateral sclerosis. Neurodegener. Dis. 2 (2005) 147-159
36. Wang S., Poptani H., Woo J.H., Desiderio L.M., Elman L.B., McCluskey L.F., Krejza J., and Melhem E.R. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology (2006)
37. Williamson L.C., Eagles D.A., Brady M.J., Moffett J.R., Namboodiri M.A., and Neale J.H. Localization and synaptic release of N-acetylaspartylglutamate in the chick retina and optic tectum. Eur. J. NeuroSci. 3 (1991) 441-451
38. Zarate C.A., and Manji H.K. Riluzole in psychiatry: a systematic review of the literature. Expert. Opin. Drug Metab. Toxicol. 4 (2008) 1223-1234